These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32115576)
41. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma. Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884 [TBL] [Abstract][Full Text] [Related]
42. The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma. Tu YS; He J; Liu H; Lee HC; Wang H; Ishizawa J; Allen JE; Andreeff M; Orlowski RZ; Davis RE; Yang J Neoplasia; 2017 Oct; 19(10):772-780. PubMed ID: 28863346 [TBL] [Abstract][Full Text] [Related]
43. Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions. Kennedy CR; Tilkens SB; Guan H; Garner JA; Or PM; Chan AM Cancer Lett; 2013 Aug; 336(2):299-306. PubMed ID: 23523615 [TBL] [Abstract][Full Text] [Related]
44. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death. Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241 [TBL] [Abstract][Full Text] [Related]
45. Novel Targeting of Transcription and Metabolism in Glioblastoma. Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993 [No Abstract] [Full Text] [Related]
46. ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of Bagheri-Yarmand R; Dadu R; Ye L; Shiny Jebaraj Y; Martinez JA; Ma J; Tarapore RS; Allen JE; Sherman SI; Williams MD; Gagel RF Mol Cancer Ther; 2021 Apr; 20(4):665-675. PubMed ID: 33536187 [TBL] [Abstract][Full Text] [Related]
47. Small molecule ONC201 inhibits HIV-1 replication in macrophages via FOXO3a and TRAIL. Zhao R; Li Y; Gorantla S; Poluektova LY; Lin H; Gao F; Wang H; Zhao J; Zheng JC; Huang Y Antiviral Res; 2019 Aug; 168():134-145. PubMed ID: 31158413 [TBL] [Abstract][Full Text] [Related]
49. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent. Zhang Q; Wang H; Ran L; Zhang Z; Jiang R Biochem Biophys Res Commun; 2016 Aug; 476(4):260-266. PubMed ID: 27233611 [TBL] [Abstract][Full Text] [Related]
50. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy. Ströbele S; Schneider M; Schneele L; Siegelin MD; Nonnenmacher L; Zhou S; Karpel-Massler G; Westhoff MA; Halatsch ME; Debatin KM PLoS One; 2015; 10(6):e0131670. PubMed ID: 26121251 [TBL] [Abstract][Full Text] [Related]
51. [The effect of oxygenation on the biological behaviour of tumours]. Sinkovics J Orv Hetil; 2007 Oct; 148(43):2056-7; author reply 2057. PubMed ID: 17947200 [No Abstract] [Full Text] [Related]
52. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87. Han L; Yuan B; Shimada R; Hayashi H; Si N; Zhao HY; Bian B; Takagi N Int J Oncol; 2018 Dec; 53(6):2488-2502. PubMed ID: 30272276 [TBL] [Abstract][Full Text] [Related]
54. MiR-200c-based metabolic modulation in glioblastoma cells as a strategy to overcome tumor chemoresistance. Cardoso AM; Morais CM; Sousa M; Rebelo O; Tão H; Barbosa M; Pedroso de Lima MC; Jurado AS Hum Mol Genet; 2021 Nov; 30(23):2315-2331. PubMed ID: 34245265 [TBL] [Abstract][Full Text] [Related]
55. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres. Park J; Shim JK; Kang JH; Choi J; Chang JH; Kim SY; Kang SG Neuro Oncol; 2018 Jun; 20(7):954-965. PubMed ID: 29294080 [TBL] [Abstract][Full Text] [Related]
56. Synthesis of novel imidazopyridines and their biological evaluation as potent anticancer agents: A promising candidate for glioblastoma. Güçlü D; Kuzu B; Tozlu İ; Taşpınar F; Canpınar H; Taşpınar M; Menges N Bioorg Med Chem Lett; 2018 Aug; 28(15):2647-2651. PubMed ID: 30042044 [TBL] [Abstract][Full Text] [Related]
57. Novel Dual PI3K/mTOR Inhibitor, Apitolisib (GDC-0980), Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells. Omeljaniuk WJ; Krętowski R; Ratajczak-Wrona W; Jabłońska E; Cechowska-Pasko M Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768941 [TBL] [Abstract][Full Text] [Related]
58. ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer. Ferrarini I; Louie A; Zhou L; El-Deiry WS Mol Cancer Ther; 2021 Sep; 20(9):1572-1583. PubMed ID: 34224362 [TBL] [Abstract][Full Text] [Related]